Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in TP53-Deficient Chronic Lymphocytic Leukemia: More Questions Than Answers.

Journal of oncology practice - 1 Jun 2017

Bociek R Gregory

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Lymphocytic, Chronic, B-Cell
Share to Mutation
Share to Prognosis
Share to Tumor Suppressor Protein p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28605619
DOI: 10.1200/JOP.2017.024554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in TP53-Deficient Chronic Lymphocytic Leukemia: More Questions Than Answers.PMID 28605619Read ↗

Chronic Lymphocytic Leukemia With TP53 Aberrations: Breakthroughs and Challenges.Semantic proximity Read ↗

Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia.Semantic proximity Read ↗

Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease.Semantic proximity Read ↗

The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia.Semantic proximity Read ↗

TP53 aberrations in chronic lymphocytic leukemia.Semantic proximity Read ↗

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapiesSemantic proximity Read ↗

Chronic lymphocytic leukemia: looking into the dark side of the genome.Semantic proximity Read ↗

Reactivating hope for TP53-mutated acute myeloid leukaemia?Semantic proximity Read ↗

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.Semantic proximity Read ↗

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignanciesSemantic proximity Read ↗

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.Semantic proximity Read ↗

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.